Kotak Securities partners with Cancer Institute (WIA) Adyar, Chennai and presents a mammogram machine for early detection of breast cancer
Chennai, 2 September 2024: Kotak Securities Limited (KSL) has partnered with Cancer Institute (WIA) Adyar, Chennai, through its Corporate Social Responsibility (CSR) initiative and presented the medical institute with a mammogram machine for early detection and treatment of breast cancer.
Through this CSR collaboration, Kotak Securities aims to cater to a large women population of Tamil Nadu and other areas. The state-of-the-art mammogram machine installed has cutting-edge capabilities to identify early signs of breast cancer, enabling timely and effective medical treatment.
Kotak Securities, under this impactful initiative, will play a pivotal role in ensuring effective diagnosis to approximately 30-35 patients per day, prioritising enhanced treatment outcomes through a smooth and fast process. Being a public charitable institute, the hospital will provide the diagnostic services either for free or at an affordable rate depending on the socio-economic status of the patient. The machine can radiologically penetrate through the layers of the breast, detect any lump or tumour and help fast-track the course of treatment.
Shripal Shah, MD & CEO, Kotak Securities, said, “Cancer Institute (WIA) Adyar has a legacy of more than 50 years of serving and treating people. We are proud to be associated with an institute of their repute. With a woman being diagnosed with breast cancer every four minutes, this cancer-detecting machine will help the institute help women from across rural parts of southern India fight the disease promptly.”
The Cancer Institute (WIA) or Adyar Cancer Institute, Chennai (https://cancerinstitutewia.in/#) is a public charitable institution dedicated to the service of cancer patients since 1954.
Dr. E. Hemanth Raj, Executive Vice Chairman, Adyar Cancer Institute said, “On behalf of the patients and staff of Cancer Institute (WIA), I would like to thank Kotak Securities Ltd., for donating the mammogram machine. This will be used by us in the diagnosis of breast cancer and also facilitating treatment in all socio-economic categories of patients. At the institute 60% of our patients are general ward patients who are treated either totally free or highly subsidized through various governmental & non-governmental welfare schemes. We are very grateful to the entire management of Kotak Securities for so willingly and proactively supporting us.”
Kotak Securities, under its CSR initiatives, implements education and livelihood programmes in addition to healthcare services.
About Kotak Securities
Kotak Securities Limited (KSL), a subsidiary of Kotak Mahindra Bank, is one of India’s largest full-service stock broking firms catering to retail and institutional investors across all segments of the capital market. Through a tie-up with partner brokers, the company also provides direct access to the US markets. Supported by a strong research team, robust digital trading platform, large branch network & franchisee base, and referral coordinators spread across Kona of India, KSL processes lakhs of secondary market trades every day. As of 30th June, 2024, KSL has a national footprint of 159 branches, 1086 franchisees and satellite offices across 315 cities in India serving 48.64 lakh active client base. KSL provides a wide array of investment options in equities, derivatives (equities, commodities, currency). It also offers depository services and third-party products like insurance and mutual funds.
For further information, contact:
Biswajit Dash
Kotak Mahindra Group
Biswajit.dash@kotak.com
+91 9167044405
Latika Srivastava
Kotak Mahindra Group
latika.srivastava@kotak.com
+91 9819344093
Raja Subramani
The Good Edge
raja@thegoodedge.com
+91 9940291904
Disclaimer
Kotak Securities Limited: CIN: U99999MH1994PLC134051, SEBI Registration No. INZ000200137 (Member of NSE, BSE, MSE, MCX & NCDEX), AMFI-registered Mutual Fund Distributor. AMFI ARN: 0164, Date of Registration: July 07, 2002, Current validity of AMFI ARN – July 23, 2027, PMS INP000000258 and Research Analyst INH000000586. NSDL/CDSL: IN-DP-629-2021.
Compliance Officer Details: Mr. Hiren Thakkar. Call: 022 – 4285 8484, or Email: ks.compliance@kotak.com.
Investments in securities market are subject to market risks, read all the related documents carefully before investing.
Please read the SEBI prescribed Combined Risk Disclosure Document prior to investing. Brokerage will not exceed SEBI prescribed limit.
For compliance T&C and disclaimers, visit https://www.kotaksecurities.com/disclaimer/
All the offers related to MTF are subject to provisions under SEBI circular CIR/MRD/DP/54/2017 dated June 13, 2017.
